- Home
- LENZ vs ANTA Comparison
LENZ vs ANTA Comparison
Compare LENZ & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LENZ | ANTA |
|---|---|---|
| Founded | 2019 | 2022 |
| Country | United States | Singapore |
| Employees | N/A | 113 |
| Industry | Medicinal Chemicals and Botanical Products | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.5M | 182.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | LENZ | ANTA |
|---|---|---|
| Price | $5.43 | $3.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $44.00 | $16.17 |
| AVG Volume (30 Days) | ★ 1.1M | 3.3K |
| Earning Date | 05-06-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,088,000.00 | N/A |
| Revenue This Year | $50.42 | $21.95 |
| Revenue Next Year | $197.16 | $30.46 |
| P/E Ratio | ★ N/A | $19.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.68 | $3.42 |
| 52 Week High | $50.19 | $13.82 |
Technical Indicators
Market Signals| Indicator | LENZ | ANTA |
|---|---|---|
| Relative Strength Index (RSI) | 43.23 | 21.54 |
| Support Level | $5.23 | N/A |
| Resistance Level | $6.21 | $9.81 |
| Average True Range (ATR) | 0.40 | 0.39 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 41.83 | 10.73 |
Price Performance
Historical ComparisonAbout LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
About ANTA Antalpha Platform Holding Company Ordinary Shares
Antalpha Platform Holding Co provides financing, technology and risk management solutions to institutional and corporate customers in the crypto asset industry. The company operates through Antalpha Prime platform in the following areas: Supply chain financing and Technology and services. Its revenue prominently consists of technology financing fees charged on the supply chain loans.